Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Options Medical Weight Loss vs RxSpan MD

By GLP-1 ScorecardUpdated

Options Medical Weight LossFactor scores not reassessed.
Site position #238

Lower score

RxSpan MD
Site position #4

Higher score

Score comparison

RxSpan MD has the higher recorded score — 84.3/100 to 65.5/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Before you choose

RxSpan MD does not publish a semaglutide price, so its RxSpan MD review sets out what it does disclose, while the Options Medical Weight Loss review explains the conditions attached to Options Medical Weight Loss's figure. The semaglutide cost page compares published rates across the field. Ask RxSpan MD for a written total before treating either one as the cheaper choice.

If neither one fits, Options Medical Weight Loss vs Synergy Rx and Pallas Health vs RxSpan MD compare each of them with another graded program, and the list of alternatives to Options Medical Weight Loss ranks the programs closest to Options Medical Weight Loss on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRxSpan MD +32
54
86
Dose & formulationRxSpan MD +12
77
89
Clinical oversightRxSpan MD +7
81
88
Labs & monitoringRxSpan MD +30
53
83
FulfillmentRxSpan MD +22
67
89
Contract termsOptions Medical Weight Loss +2
55
53
Options Medical Weight Loss · top barRxSpan MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricOptions Medical Weight LossRxSpan MD
WeighScore65.5/10084.3/100
GradeCB
Site position#238#4
SemaglutideFrom $199/mo (compounded program, selected quote required)Current compounded quote unconfirmed
TirzepatideFrom $399/mo (compounded program, selected quote required)Current compounded quote unconfirmed
CoverageCoverage not publishedConfirm treatment availability during intake
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Options Medical Weight Loss

Site position #238 · C

Factor scores not reassessed.

Strengths

  • Advertises a free consultation.
  • Describes coaching and metabolic tracking as part of its GLP-1 program.

What to consider

  • The advertised starting figures do not establish a selected program charge.
  • Confirm any visit or testing fees and the cancellation terms.
RxSpan MD

Site position #4 · B

Strengths

  • Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
  • Public terms describe independent healthcare providers
  • Homepage describes messaging and care-team appointments

What to consider

  • Homepage advertises compounded plans that the current catalog did not substantiate
  • Current oral GLP-1 availability is unconfirmed
  • Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
  • Public terms do not establish unused prepaid-treatment refund amounts

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard